Brad Hirakawa

17 papers and 520 indexed citations i.

About

Brad Hirakawa is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Brad Hirakawa has authored 17 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Brad Hirakawa’s work include Cell death mechanisms and regulation (3 papers), Advanced Breast Cancer Therapies (2 papers) and Mechanisms of Drug-Induced Hepatotoxicity (2 papers). Brad Hirakawa is often cited by papers focused on Cell death mechanisms and regulation (3 papers), Advanced Breast Cancer Therapies (2 papers) and Mechanisms of Drug-Induced Hepatotoxicity (2 papers). Brad Hirakawa collaborates with scholars based in United States, United Kingdom and Australia. Brad Hirakawa's co-authors include Bart Jessen, Shem Patyna, Yvonne Will, Joseph Jamieson, Sashi Nadanaciva, James A. Dykens, Lisa D. Marroquin, James T. Hynes, Craig D. Fisher and Niel C. Hoglen and has published in prestigious journals such as Hepatology, Journal of Pharmacology and Experimental Therapeutics and Nature Chemical Biology.

In The Last Decade

Co-authorship network of co-authors of Brad Hirakawa i

Fields of papers citing papers by Brad Hirakawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brad Hirakawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad Hirakawa. The network helps show where Brad Hirakawa may publish in the future.

Countries citing papers authored by Brad Hirakawa

Since Specialization
Citations

This map shows the geographic impact of Brad Hirakawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad Hirakawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad Hirakawa more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2025